How much funding has Novotech Holdings raised?

Novotech Holdings has raised $2.7B in total funding, most recently a Private Equity round.

Who are Novotech Holdings's investors?

Novotech Holdings's investors include GIC, Temasek, TPG (Growth/Rise).

When was Novotech Holdings founded?

Novotech Holdings was founded in 1997.

Where is Novotech Holdings headquartered?

Novotech Holdings is headquartered in Singapore, Australia.

What industry is Novotech Holdings in?

Novotech Holdings operates in Biotech, Healthcare.

How many employees does Novotech Holdings have?

Novotech Holdings has 1001-5000 employees.

Novotech Holdings

Biotech's Partner at Every Phase | Novotech CRO

Singapore, Australia · Founded 1997 · $2.7B raised

Biotech

Healthcare

Headquarters: Singapore
Employees: 1001–5000
Founded: 1997
Business Model: B2B

Website: novotech-cro.com
Total Funding: $2.7B
Last Round: $760.0M Private EquityMar 2025
Rounds: 2

About

Novotech is a globally recognized full-service clinical research organization (CRO) founded in 1997 in Australia and now headquartered in Singapore. It provides biotech and pharmaceutical companies with clinical trial services across Asia-Pacific, North America, and Europe, with expertise in oncology, rare diseases, and early-phase trials.

Summary

Novotech Holdings is a Biotech company based in Singapore, Australia, founded in 1997. It has raised $2.7B in total across 2 rounds, most recently a $760.0M Private Equity round in Mar 2025. Investors include GIC, Temasek and TPG (Growth/Rise).

LinkedIn X (Twitter)